Use of mucolytics in COPD: A Delphi consensus study-Reference-Cited by-同舟云学术

Use of mucolytics in COPD: A Delphi consensus study

Published:2020-12 Issue: Volume:175 Page:106190
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Papi Alberto,Avdeev Sergey,Calverley Peter M.A.,Cordeiro Carlos R.,Jesenak Milos,Koblížek Vladimir,Petkova Diana,Rogliani Paola,Tarraf Hesham,Tzanakis Nikolaos,Ulmeanu Ruxandra,Uzaslan Esra,Adir Yochai

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference34 articles.

1. Global Strategy for Diagnosis, Management and Prevention of COPD,2020

2. J.A. Krishnan. Prevention of COPD exacerbations: a European respiratory society/American thoracic society guideline;Wedzicha;Eur. Respir. J.,2017

3. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease;Donaldson;Thorax,2002

4. Changes in forced expiratory volume in 1 second over time in COPD;Vestbo;N. Engl. J. Med.,2011

5. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease;Seemungal;Am. J. Respir. Crit. Care Med.,1998

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A double‐blind randomized controlled trial of N‐acetylcysteine (NAC) for the treatment of acute exacerbation of chronic obstructive pulmonary disease;Respirology Case Reports;2024-08

2. Role of airway epithelium in viral respiratory infections: Can carbocysteine prevent or mitigate them?;Immunology;2024-02-14

3. Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD;Respiratory Research;2023-07-31

4. The potential of erdosteine to reduce the rate of exacerbations of chronic obstructive pulmonary disease;PULMONOLOGIYA;2022-05-01

5. The Role of Non-Typeable Haemophilus influenzae Biofilms in Chronic Obstructive Pulmonary Disease;Frontiers in Cellular and Infection Microbiology;2021-08-04